메뉴 건너뛰기




Volumn 29, Issue 3, 2014, Pages 227-234

Pharmacogenetics of heart failure

Author keywords

cardiovascular genetics; drug response; genetic variation; heart failure; pharmacogenomics

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2C ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DOFETILIDE; ENDOTHELIN; QUINIDINE; SOTALOL; WARFARIN; ADRENERGIC RECEPTOR; CARDIOVASCULAR AGENT; ENDOTHELIN RECEPTOR;

EID: 84899474143     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000056     Document Type: Review
Times cited : (7)

References (30)
  • 1
    • 84877596833 scopus 로고    scopus 로고
    • The 1000 Genomes Project Consortium An integrated map of genetic variation from 1092 human genomes
    • Abecasis GR, Auton A, Brooks LD, et al., The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1092 human genomes. Nature 2012; 491:56-65.
    • (2012) Nature , vol.491 , pp. 56-65
    • Abecasis, G.R.1    Auton, A.2    Brooks, L.D.3
  • 2
  • 4
    • 84863705458 scopus 로고    scopus 로고
    • Personalized medicine: Hope or hype?
    • Salari K, Watkins H, Ashley EA. Personalized medicine: hope or hype? Eur Heart J 2012; 33:1564-1570.
    • (2012) Eur Heart J , vol.33 , pp. 1564-1570
    • Salari, K.1    Watkins, H.2    Ashley, E.A.3
  • 5
    • 75549084134 scopus 로고    scopus 로고
    • Personalized genomic information: Preparing for the future of genetic medicine
    • Guttmacher AE, McGuire AL, Ponder B, Stefansson K. Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet 2010; 11:161-165.
    • (2010) Nat Rev Genet , vol.11 , pp. 161-165
    • Guttmacher, A.E.1    McGuire, A.L.2    Ponder, B.3    Stefansson, K.4
  • 6
    • 84891820778 scopus 로고    scopus 로고
    • Coronary artery disease risk loci identified in over 190 000 individuals implicate lipid metabolism and inflammation as key causal pathways
    • The CARDIoGRAMplusC4D Consortium
    • The CARDIoGRAMplusC4D Consortium. Coronary artery disease risk loci identified in over 190 000 individuals implicate lipid metabolism and inflammation as key causal pathways. Nat Genet 2013; 45:25-33.
    • (2013) Nat Genet , vol.45 , pp. 25-33
  • 7
    • 84899474573 scopus 로고    scopus 로고
    • On Behalf of the NHLBIGO Exome Sequencing Project Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset
    • Accessed on March 5 2014 Epub ahead of print
    • Gordon AS, Tabor HK, Johnson AD, et al.,On Behalf of the NHLBIGO Exome Sequencing Project. Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset [Accessed on March 5, 2014]. Hum Mol Genet 2013. [Epub ahead of print]
    • (2013) Hum Mol Genet
    • Gordon, A.S.1    Tabor, H.K.2    Johnson, A.D.3
  • 8
    • 0028041629 scopus 로고
    • Economic impact of heart failure in the United States: Time for a different approach
    • O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13:S107-S112.
    • (1994) J Heart Lung Transplant , vol.13
    • O'Connell, J.B.1    Bristow, M.R.2
  • 9
    • 84899491296 scopus 로고    scopus 로고
    • Dilated cardiomyopathies
    • Fuster V, Walsh RA, Harrington RA, editors 13th ed. New York: The McGraw-Hill Companies, Inc Chapter 32
    • Mestroni LJ, Gilbert EM, Lowes BL, Bristow RM. Dilated cardiomyopathies. In: Fuster V, Walsh RA, Harrington RA, editors. Hurst's the heart, 13th ed. New York: The McGraw-Hill Companies, Inc; 2011. pp. 821-836. Chapter 32.
    • (2011) Hurst's the Heart , pp. 821-836
    • Mestroni, L.J.1    Gilbert, E.M.2    Lowes, B.L.3    Bristow, R.M.4
  • 10
    • 84857363880 scopus 로고    scopus 로고
    • Pharmacogenetic targeting of drugs for heart failure
    • Bristow MR. Pharmacogenetic targeting of drugs for heart failure. Pharmacol Ther 2012; 134:107-115.
    • (2012) Pharmacol Ther , vol.134 , pp. 107-115
    • Bristow, M.R.1
  • 11
    • 58149267604 scopus 로고    scopus 로고
    • Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure
    • Taylor MR, Slavov D, Humphrey K, et al. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenet Genomics 2009; 19:35-43.
    • (2009) Pharmacogenet Genomics , vol.19 , pp. 35-43
    • Taylor, M.R.1    Slavov, D.2    Humphrey, K.3
  • 12
    • 0037057235 scopus 로고    scopus 로고
    • Synergistic polymorphisms of beta1-and alpha2C-adrenergic receptors and the risk of congestive heart failure
    • Small KM, Wagoner LE, Levin AM, et al. Synergistic polymorphisms of beta1-and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347:1135-1142.
    • (2002) N Engl J Med , vol.347 , pp. 1135-1142
    • Small, K.M.1    Wagoner, L.E.2    Levin, A.M.3
  • 13
    • 33745902221 scopus 로고    scopus 로고
    • Association of parental heart failure with risk of heart failure in offspring
    • Lee DS, Pencina MJ, Benjamin EJ, et al. Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 2006; 355:138-147.
    • (2006) N Engl J Med , vol.355 , pp. 138-147
    • Lee, D.S.1    Pencina, M.J.2    Benjamin, E.J.3
  • 14
    • 77955868822 scopus 로고    scopus 로고
    • Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: A prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium
    • Smith NL, Felix JF, Morrison AC, et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Circ Cardiovasc Genet 2010; 3:256-266.
    • (2010) Circ Cardiovasc Genet , vol.3 , pp. 256-266
    • Smith, N.L.1    Felix, J.F.2    Morrison, A.C.3
  • 15
    • 77955909864 scopus 로고    scopus 로고
    • Genomic variation associated with mortality among adults of European and African ancestry with heart failure: The cohorts for heart and aging research in genomic epidemiology consortium
    • Morrison AC, Felix JF, Cupples LA, et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet 2010; 3:248-255.
    • (2010) Circ Cardiovasc Genet , vol.3 , pp. 248-255
    • Morrison, A.C.1    Felix, J.F.2    Cupples, L.A.3
  • 16
    • 41749117082 scopus 로고    scopus 로고
    • Emerging role of pharmacogenomics in heart failure
    • McNamara DM. Emerging role of pharmacogenomics in heart failure. Curr Opin Cardiol 2008; 23:261-268.
    • (2008) Curr Opin Cardiol , vol.23 , pp. 261-268
    • McNamara, D.M.1
  • 17
    • 79958085599 scopus 로고    scopus 로고
    • Cardiovascular pharmacogenomics and individualized drug therapy
    • Pereira NL, Weinshilboum RM. Cardiovascular pharmacogenomics and individualized drug therapy. Nat Rev Cardiol 2009; 6:632-638.
    • (2009) Nat Rev Cardiol , vol.6 , pp. 632-638
    • Pereira, N.L.1    Weinshilboum, R.M.2
  • 18
    • 34247593030 scopus 로고    scopus 로고
    • Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure
    • Lobmeyer MT, Gong Y, Terra SG, et al. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure. Pharmacogenet Genomics 2007; 17:277-282.
    • (2007) Pharmacogenet Genomics , vol.17 , pp. 277-282
    • Lobmeyer, M.T.1    Gong, Y.2    Terra, S.G.3
  • 19
    • 76549133595 scopus 로고    scopus 로고
    • An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure
    • Bristow MR, Murphy GA, Krause-Steinrauf H, et al. An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure. Circ Heart Fail 2010; 3:21-28.
    • (2010) Circ Heart Fail , vol.3 , pp. 21-28
    • Bristow, M.R.1    Murphy, G.A.2    Krause-Steinrauf, H.3
  • 20
    • 0032836517 scopus 로고    scopus 로고
    • Vasodilator-Heart Failure Trial Study Group. Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
    • Carson P, Ziesche S, Johnson G, Cohn JN, Vasodilator-Heart Failure Trial Study Group. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. J Card Fail 1999; 5:178-187.
    • (1999) J Card Fail , vol.5 , pp. 178-187
    • Carson, P.1    Ziesche, S.2    Johnson, G.3    Cohn, J.N.4
  • 21
    • 33748079774 scopus 로고    scopus 로고
    • Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G-protein beta3 subunit (GNB3) c825t polymorphism
    • Wieneke H, Naber CN, Piaszek L, et al. Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G-protein beta3 subunit (GNB3) c825t polymorphism. Basic Res Cardiol 2006; 101:447-451.
    • (2006) Basic Res Cardiol , vol.101 , pp. 447-451
    • Wieneke, H.1    Naber, C.N.2    Piaszek, L.3
  • 22
    • 84856164890 scopus 로고    scopus 로고
    • A systematic review on pharmacogenetics in cardiovascular disease: Is it ready for clinical application?
    • Verschuren JJ, Trompet S, Wessels JA, et al. A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? Eur Heart J 2012; 33:165-175.
    • (2012) Eur Heart J , vol.33 , pp. 165-175
    • Verschuren, J.J.1    Trompet, S.2    Wessels, J.A.3
  • 23
    • 84863631944 scopus 로고    scopus 로고
    • Genetics and cardiovascular disease: A policy statement from the American Heart Association
    • Ashley EA, Hershberger RE, Caleshu C, et al. Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation 2012; 126:142-157.
    • (2012) Circulation , vol.126 , pp. 142-157
    • Ashley, E.A.1    Hershberger, R.E.2    Caleshu, C.3
  • 24
    • 80052969185 scopus 로고    scopus 로고
    • Pharmacogenomics: Application to the management of cardiovascular disease
    • Johnson JA, Cavallari LH, Beitelshees AL, et al. Pharmacogenomics: application to the management of cardiovascular disease. Clin Pharmacol Ther 2011; 90:519-531.
    • (2011) Clin Pharmacol Ther , vol.90 , pp. 519-531
    • Johnson, J.A.1    Cavallari, L.H.2    Beitelshees, A.L.3
  • 25
    • 84890988743 scopus 로고    scopus 로고
    • Genetics and genomics for the prevention and treatment of cardiovascular disease: Update A scientific statement from the American Heart Association
    • Ganesh SK, Arnett DK, Assimes TL, et al. Genetics and genomics for the prevention and treatment of cardiovascular disease: update. A scientific statement from the American Heart Association. Circulation 2013; 128:2813-2851.
    • (2013) Circulation , vol.128 , pp. 2813-2851
    • Ganesh, S.K.1    Arnett, D.K.2    Assimes, T.L.3
  • 26
    • 84889873119 scopus 로고    scopus 로고
    • EU-PACT Group. A randomized trial of genotype-guided dosing of warfarin
    • Pirmohamed M, Burnside G, Eriksson N, et al., EU-PACT Group. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013; 369:2294-2303.
    • (2013) N Engl J Med , vol.369 , pp. 2294-2303
    • Pirmohamed, M.1    Burnside, G.2    Eriksson, N.3
  • 27
    • 84889824971 scopus 로고    scopus 로고
    • COAG Investigators. A pharmacogenetic versus a clinical algorithm for warfarin dosing
    • Kimmel SE, French B, Kasner SE, et al., COAG Investigators. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 2013; 369:2283-2293.
    • (2013) N Engl J Med , vol.369 , pp. 2283-2293
    • Kimmel, S.E.1    French, B.2    Kasner, S.E.3
  • 28
    • 84876998756 scopus 로고    scopus 로고
    • Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: A review of ticagrelor
    • Davis EM, Knezevich JT, Teply RM. Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor. Clin Pharmacol 2013; 5:67-83.
    • (2013) Clin Pharmacol , vol.5 , pp. 67-83
    • Davis, E.M.1    Knezevich, J.T.2    Teply, R.M.3
  • 29
    • 17444439098 scopus 로고    scopus 로고
    • Polymorphisms of the beta( 2)-adrenergic receptor determine exercise capacity in patients with heart failure
    • Wagoner LE, Craft LL, Singh B, et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 2000; 86:834-840.
    • (2000) Circ Res , vol.86 , pp. 834-840
    • Wagoner, L.E.1    Craft, L.L.2    Singh, B.3
  • 30
    • 84881148332 scopus 로고    scopus 로고
    • Biomarker-guided therapies in heart failure: A forum for unified strategies
    • Fiuzat M, O'Connor CM, Gueyffier F, et al. Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail 2013; 19:592-599.
    • (2013) J Card Fail , vol.19 , pp. 592-599
    • Fiuzat, M.1    O'Connor, C.M.2    Gueyffier, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.